A Multi-Centre, Randomised, Double Blind, Placebo Controlled, Parallel Group Study of TA 8995 in Patients with Mild Dyslipidaemia, Alone and In Combination with Statin Therapy
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Obicetrapib (Primary) ; Atorvastatin; Rosuvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- Acronyms TULIP
- Sponsors Xention
- 01 Aug 2015 Results published in the Lancet.
- 29 Aug 2014 Primary endpoint has been met. (Change in both HDL-C and LDL-C levels at Week 12)
- 29 Aug 2014 Results published in the Media Release.